Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

EULAR 2012: Does Arthritis Start in the Gut?

Thomas R. Collins  |  Issue: August 2012  |  August 8, 2012

He also presented evidence suggesting that Chlamydia could be a cause of undifferentiated spondylarthropathy (uSpA).

Researchers at the University of South Florida tested 26 subjects with uSpA for Chlamydia in synovial tissue against 167 controls with osteoarthritis, finding significantly higher levels of Chlamydia in the uSpA patients. Sixty-two percent of them were positive for C. trachomatis, Chlamydophila pneumonia, or both, compared with 12% in the control group.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Perhaps reactive arthritis can be used as a model for all the spondylarthridities,” Dr. Carter said. “These data suggest a blurring of the line between infection and arthritis.” the rheumatologist


Thomas Collins is a freelance medical writer based in Florida.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Gerard HC, Stanich JA, Whittum-Hudson JA, Schumacher HR, Carter JD, Hudson AP. Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog. 2010;48:62-68.

Page: 1 2 3 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsEULAR/OtherMeeting ReportsResearch Rheum Tagged with:EULARgut microbiomeInternationalReactive arthritisResearch

Related Articles

    Reactive Arthritis

    October 1, 2010

    Back to the Future

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Treatment Patterns and Trends for Spondylarthropathies

    April 6, 2012

    Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences